Larimar Therapeutics, Inc.

LRMR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
DEFA14A Feb 5, 2020 DEFA14A
8-K Feb 5, 2020 8-K
SC 13G/A Feb 4, 2020 SC 13G/A
8-K Jan 13, 2020 8-K
DEFA14A Jan 13, 2020 8-K
SC 13D Dec 27, 2019 SCHEDULE 13D
SC 13G/A Dec 19, 2019 AMENDMENT TO FORM SC 13G
DEFA14A Dec 18, 2019 DEFA14A
8-K Dec 18, 2019 8-K
DEFA14A Dec 18, 2019 8-K
S-8 Nov 7, 2019 S-8
10-Q Nov 6, 2019 10-Q
8-K Nov 6, 2019 8-K
SC 13G Oct 15, 2019
SC 13G/A Oct 10, 2019
8-K Sep 19, 2019 8-K
SC 13G/A Sep 18, 2019 AMENDED FORM SC 13G
SC 13G Sep 16, 2019 SEPTEMBER 5, 2019
8-K Sep 12, 2019 8-K
SC 13G Aug 16, 2019 ACQUISITION OF BENEFICIAL OWNERSHIP
10-Q Aug 8, 2019 10-Q
8-K Aug 8, 2019 8-K
SC 13G/A Jul 10, 2019
4 Jun 27, 2019 FORM 4 SUBMISSION
4 Jun 27, 2019 FORM 4 SUBMISSION
← Newer Page 15 of 28 · 696 filings Older →